Published in Int Urogynecol J on September 20, 2011
Diagnosis and Therapy of Female Pelvic Organ Prolapse. Guideline of the DGGG, SGGG and OEGGG (S2e-Level, AWMF Registry Number 015/006, April 2016). Geburtshilfe Frauenheilkd (2016) 0.75
An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J (2009) 7.12
Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol (2002) 5.73
Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev (2009) 4.98
Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev (2009) 3.54
A new look at pelvic relaxation. Am J Obstet Gynecol (1976) 2.07
Urinary incontinence in women: variation in prevalence estimates and risk factors. Obstet Gynecol (2008) 1.67
Surgical management of anterior vaginal wall prolapse: an evidencebased literature review. Int Urogynecol J Pelvic Floor Dysfunct (2005) 1.55
Treatment of stress urinary incontinence due to paravaginal fascial defect. Obstet Gynecol (1981) 1.50
Vaginal paravaginal repair using porcine or human cadaveric dermal implant: a survival analysis. Int Surg (2010) 1.38
A 3D finite element model of anterior vaginal wall support to evaluate mechanisms underlying cystocele formation. J Biomech (2009) 1.38
Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database Syst Rev (2011) 1.14
Surgical management of prolapse of the anterior vaginal segment: an analysis of support defects, operative morbidity, and anatomic outcome. Am J Obstet Gynecol (1994) 1.08
Vaginal paravaginal repair: one-year outcomes. Am J Obstet Gynecol (2001) 0.86
Paravaginal defect repair in the treatment of female stress urinary incontinence and cystocele. Urology (1999) 0.84
Paravaginal repair of lateral vaginal wall defects by fixation to the ischial periosteum and obturator membrane. Am J Obstet Gynecol (1998) 0.83
Anatomic outcomes of abdominal sacrocolpopexy with or without paravaginal repair. Int Urogynecol J (2010) 0.82
Anatomic and functional outcome of vaginal paravaginal repair in the correction of anterior vaginal wall prolapse. Int Urogynecol J Pelvic Floor Dysfunct (2001) 0.81
A six-year experience with paravaginal defect repair for stress urinary incontinence. Am J Obstet Gynecol (1989) 0.81
Laparoscopic paravaginal repair plus burch colposuspension: review and descriptive technique. Urology (2000) 0.81
Site-specific prolapse surgery. II. Vaginal paravaginal repair augmented with either synthetic mesh or remodelling xenograft. Int Urogynecol J (2011) 0.80
Vaginal paravaginal repair with an AlloDerm graft: Long-term outcomes. Am J Obstet Gynecol (2007) 0.80
Cystocele - vaginal approach to repairing paravaginal fascial defects. Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.79
Laparoscopic paravaginal repair of anterior compartment prolapse. J Minim Invasive Gynecol (2007) 0.78
[Mini-invasive posterior sacrospinous ligament fixation using the CAPIO needle driver: an anatomical study]. Prog Urol (2010) 0.78
Site-specific prolapse surgery. I. Reliability and durability of native tissue paravaginal repair. Int Urogynecol J (2011) 0.75
Bowel endometriosis: presentation, diagnosis, and treatment. Obstet Gynecol Surv (2007) 2.29
Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma. J Clin Oncol (2010) 2.25
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood (2013) 2.14
Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP. Blood (2012) 1.42
A case of transposition of the great arteries in a female infant of a HIV-1-infected woman. Potential teratogenic effects of antiretroviral drugs. Intern Emerg Med (2006) 1.39
Unidirectional barbed suture versus continuous suture with intracorporeal knots in laparoscopic myomectomy: a randomized study. J Minim Invasive Gynecol (2010) 1.35
Rising use of synthetic mesh in transvaginal pelvic reconstructive surgery: a review of the risk of vaginal erosion. J Minim Invasive Gynecol (2007) 1.21
Neoadjuvant chemotherapy and vaginal radical trachelectomy for fertility-sparing treatment in women affected by cervical cancer (FIGO stage IB-IIA1). Gynecol Oncol (2011) 1.17
Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation. Haematologica (2003) 1.15
New case of acute hepatitis following the consumption of Shou Wu Pian, a Chinese herbal product derived from Polygonum multiflorum. Ann Intern Med (2004) 1.14
Operative time required to perform sacrospinous ligament suspension. Arch Gynecol Obstet (2013) 1.08
Value of urodynamics before stress urinary incontinence surgery: a randomized controlled trial. Obstet Gynecol (2013) 1.08
Hyperemesis gravidarum: measurement of total and active ghrelin levels. Arch Gynecol Obstet (2013) 1.08
CD10 in the cytological diagnosis of endobronchial endometriosis. Pediatr Pulmonol (2007) 1.06
Multislice CT enteroclysis in the diagnosis of bowel endometriosis. Eur Radiol (2006) 1.03
Randomized study of laparoscopic versus minilaparotomic myomectomy for uterine myomas. J Minim Invasive Gynecol (2006) 1.02
Bowel preparation before laparoscopic gynaecological surgery in benign conditions using a 1-week low fibre diet: a surgeon blind, randomized and controlled trial. Arch Gynecol Obstet (2009) 1.00
Letrozole and desogestrel-only contraceptive pill for the treatment of stage IV endometriosis. Aust N Z J Obstet Gynaecol (2007) 0.94
Feasibility of axillary reverse mapping during sentinel lymph node biopsy in breast cancer patients. Ann Surg Oncol (2009) 0.93
Letrozole and norethisterone acetate in rectovaginal endometriosis. Fertil Steril (2007) 0.93
Safety and efficacy of vaginal hysterectomy in the large uterus with the LigaSure bipolar diathermy system. Am J Obstet Gynecol (2008) 0.92
Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH. Nephron (2002) 0.91
Incontinence outcomes in women undergoing primary and repeat midurethral sling procedures. Obstet Gynecol (2013) 0.91
A prospective, randomized trial comparing immediate versus delayed catheter removal following hysterectomy. Acta Obstet Gynecol Scand (2006) 0.90
Peritoneal fluid macrophages in endometriosis: correlation between the expression of estrogen receptors and inflammation. Fertil Steril (2007) 0.90
Methodological concerns regarding levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum Reprod (2004) 0.89
Peripartum cardiomyopathy. Arch Gynecol Obstet (2009) 0.88
Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females. Expert Opin Drug Metab Toxicol (2012) 0.88
Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. Ann Surg Oncol (2009) 0.87
A randomized comparison of suturing techniques for episiotomy and laceration repair after spontaneous vaginal birth. J Minim Invasive Gynecol (2006) 0.87
Pharmacokinetic and toxicity considerations for the use of anthracyclines in ovarian cancer treatment. Expert Opin Drug Metab Toxicol (2011) 0.86
Oxaliplatin for the treatment of ovarian cancer. Expert Opin Investig Drugs (2015) 0.85
Periurethral injection of polyacrylamide hydrogel for the treatment of stress urinary incontinence: the impact on female sexual function. J Sex Med (2012) 0.84
Evaluation of five elements in lenses and aqueous humour of experimental rabbits after induced opacity. J Trace Elem Med Biol (2004) 0.84
Bowel endometriosis: CT-enteroclysis. Abdom Imaging (2007) 0.83
Targeting tyrosine-kinases in ovarian cancer. Expert Opin Investig Drugs (2013) 0.83
Transvaginal ultrasonography combined with water-contrast in the rectum in the diagnosis of rectovaginal endometriosis infiltrating the bowel. Fertil Steril (2007) 0.83
Role of estrogens in inflammatory response: expression of estrogen receptors in peritoneal fluid macrophages from endometriosis. Ann N Y Acad Sci (2006) 0.82
Endometriosis presenting with hemorrhagic ascites. Arch Gynecol Obstet (2010) 0.82
Atherosclerosis in women with endometriosis. Eur J Obstet Gynecol Reprod Biol (2006) 0.82
The efficacy of 2002 CDC guidelines in preventing perinatal group B Streptococcal vertical transmission: a prospective study. Arch Gynecol Obstet (2006) 0.82
Rectosigmoid endometriosis with unusual presentation at magnetic resonance imaging. Fertil Steril (2008) 0.82
Transvaginal sonohysterographic evaluation of uterine malformations. Eur J Obstet Gynecol Reprod Biol (2005) 0.81
Outcomes of the first midwife-led birth centre in Italy: 5 years' experience. Arch Gynecol Obstet (2007) 0.81
The association between p53 expression, stage and histological features in endometrial cancer. Eur J Obstet Gynecol Reprod Biol (2005) 0.80
Triptorelin for the treatment of endometriosis. Expert Opin Pharmacother (2014) 0.80
Mirabegron in the treatment of overactive bladder. Expert Opin Pharmacother (2014) 0.80
The potential of sunitinib as a therapy in ovarian cancer. Expert Opin Investig Drugs (2013) 0.79
Monoclonal antibodies therapies for ovarian cancer. Expert Opin Biol Ther (2013) 0.79
The preoperative diagnosis of borderline ovarian tumors: a review of current literature. Arch Gynecol Obstet (2011) 0.79
Endometriosis in menopause: a single institution experience. Arch Gynecol Obstet (2012) 0.79
Axillary reverse mapping in breast cancer: a new microsurgical lymphatic-venous procedure in the prevention of arm lymphedema. Ann Surg Oncol (2008) 0.78
Changes in sexual function after medical or surgical termination of pregnancy. J Sex Med (2014) 0.78
Evaluation of endometrial thickness in hormone receptor positive early stage breast cancer postmenopausal women switching from adjuvant tamoxifen treatment to anastrozole. Breast (2008) 0.78
Imidafenacin for the treatment of overactive bladder. Expert Opin Pharmacother (2013) 0.78
Letrozole monotherapy in the treatment of uterine myomas. Fertil Steril (2010) 0.78
Drug safety evaluation of ulipristal acetate in the treatment of uterine fibroids. Expert Opin Drug Saf (2015) 0.77
Differences between plasma and serum vascular endothelial growth factor. Am J Cardiol (2006) 0.77
Vaginal sacrospinous colpopexy using the Capio suture-capturing device versus traditional technique: feasibility and outcome. Arch Gynecol Obstet (2012) 0.77
Outpatient periurethral injections of polyacrylamide hydrogel for the treatment of female stress urinary incontinence: effectiveness and safety. Arch Gynecol Obstet (2013) 0.77
Defective placental adhesion in voluntary termination of second-trimester pregnancy and risk of recurrence in subsequent pregnancies. J Matern Fetal Neonatal Med (2011) 0.77
Endometrial directed biopsy during sonohysterography using the NiGo device: prospective study in women with abnormal uterine bleeding. Fertil Steril (2007) 0.76
An evaluation of the pharmacokinetics and pharmacodynamics of ivabradine for the treatment of heart failure. Expert Opin Drug Metab Toxicol (2013) 0.76
Cardiovascular effects of antimuscarinic agents in overactive bladder. Expert Opin Drug Saf (2013) 0.76
Sorafenib for ovarian cancer. Expert Opin Investig Drugs (2013) 0.76
Pre- and post-operative work-up in patients affected by early cervical cancer and eligible for fertility-sparing treatment: role of MRI with saline hydrocolpos. Abdom Imaging (2009) 0.76
Irritable bowel syndrome and endometriosis. Eur J Gastroenterol Hepatol (2005) 0.76
Prognostic value of plasma and serum VEGF levels in patients with resectable hepatocellular carcinoma. Ann Surg Oncol (2003) 0.76
Current opinion on bevacizumab on endometrial cancer treatment. Expert Opin Biol Ther (2014) 0.76
VEGF levels in patients with peripheral arterial occlusive disease receiving LDL-apheresis. J Clin Apher (2004) 0.75
Is circulating extracellular VEGF increased in preeclamptic women? Am J Obstet Gynecol (2005) 0.75
Is VEGF a marker for ovarian response and pregnancy outcome? Eur J Obstet Gynecol Reprod Biol (2005) 0.75
Abdominal pain, bloating, and urgency. Obstet Gynecol (2005) 0.75
Measurement of circulating vascular endothelial growth factor in obese subjects. J Am Coll Cardiol (2004) 0.75
Antiangiogenic drugs in the treatment of endometriosis. Reprod Sci (2012) 0.75
Concerns in reporting of serum vascular endothelial growth factor levels: comment on the article by Nakahara et al. Arthritis Rheum (2004) 0.75
Is measurement of serum vascular endothelial growth factor reliable in patients with active pulmonary tuberculosis? Chest (2005) 0.75
Is measurement of serum vascular endothelial growth factor reliable in patients with systemic sclerosis? J Rheumatol (2004) 0.75
Lymphedema microsurgical preventive healing approach for primary prevention of lower limb lymphedema after inguinofemoral lymphadenectomy for vulvar cancer. Int J Gynecol Cancer (2013) 0.75
Active ghrelin levels during fetal life and childhood. J Pediatr (2004) 0.75
Pitfalls in the measurement of serum VEGF in children with congenital heart disease. Ann Thorac Surg (2004) 0.75
"Triple marker" for ectopic pregnancy. Fertil Steril (2004) 0.75
Endometriosis at 2nd surgery--residual or recurrent disease. Fertil Steril (2005) 0.75
Angiogenic factors in serum of patients with testicular germ cell tumours. Urol Res (2004) 0.75
Serum levels of mast cell tryptase, vascular endothelial growth factor, and basic fibroblast growth factor in patients with acute pancreatitis. Pancreas (2004) 0.75
Octanoylated and nonoctanoylated ghrelin levels in cord blood. Clin Endocrinol (Oxf) (2004) 0.75
N-octanoylated ghrelin levels in cord and neonatal blood. J Clin Endocrinol Metab (2004) 0.75
Matalliotakis IM, Goumenou AG, Koumantakis GE, Neonaki MA, Koumantakis EE, Dionyssopoulou E, Athanassakis I, Vassiliadis S. Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines [Int Immunopharmacol 2003; 3(1):81-89]. Int Immunopharmacol (2004) 0.75
Vascular endothelial growth factor, persistent disease, and survival in ovarian cancer. Gynecol Oncol (2005) 0.75
Investigational therapies currently in Phase II clinical trials for the treatment of pelvic serous carcinomas. Expert Opin Investig Drugs (2015) 0.75
Bevacizumab in endometrial cancer treatment. Expert Opin Biol Ther (2012) 0.75
Data quality improvement of a multicenter clinical trial dataset. Conf Proc IEEE Eng Med Biol Soc (2017) 0.75
Intestinal Endometriosis: Mimicker of Inflammatory Bowel Disease? Digestion (2015) 0.75
Fetal Tricuspid Regurgitation in the First Trimester as a Screening Marker for Congenital Heart Defects: Systematic Review and Meta-Analysis. Fetal Diagn Ther (2017) 0.75
The value of sonohysterography in detecting intracavitary benign abnormalities. Arch Gynecol Obstet (2005) 0.75
MDCT enteroclysis urography with split-bolus technique provides information on ureteral involvement in patients with suspected bowel endometriosis. AJR Am J Roentgenol (2011) 0.75
Selection of patients with high risk endometrial cancer for surgical staging according to the evaluation of pre- and intraoperative risk factors. Minerva Ginecol (2016) 0.75
Ranolazine for the treatment of atrial fibrillation. Expert Opin Investig Drugs (2015) 0.75